VALBIOTIS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.15 EUR | -2.24% |
|
-5.03% | -17.00% |
| 04-26 | Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 04-03 | Valbiotis: launch of Valbiotis PRO Cholesterol in May | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 72.75M | - | |||||
| 115B | ||||||
| 107B | ||||||
| 22.31B | - | |||||
| 21.6B | - | |||||
| 18.23B | - |
- Stock Market
- Equities
- ALVAL Stock
- Charts VALBIOTIS
- Sector Chart
